Literature DB >> 16532003

A sensitive and high-throughput assay to detect low-abundance proteins in serum.

Hongtao Zhang1, Xin Cheng, Mark Richter, Mark I Greene.   

Abstract

The ability to detect antigens immunologically is limited by the affinity of the antibodies and the amount of antigens. We have now succeeded in creating a modular, facile amplification system, termed fluorescent amplification catalyzed by T7 polymerase technique (FACTT). Such a system can detect protein targets specifically at subfemtomolar levels ( approximately 0.08 fM). We describe here the detection of Her2 (also known as Neu) from rodent and human sera. FACTT is adaptable to high-throughput screening and automation and provides a practical method to enhance current ELISAs in medical practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16532003     DOI: 10.1038/nm1378

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  19 in total

Review 1.  ErbB receptors: from oncogenes to targeted cancer therapies.

Authors:  Hongtao Zhang; Alan Berezov; Qiang Wang; Geng Zhang; Jeffrey Drebin; Ramachandran Murali; Mark I Greene
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 2.  Nanotechnology and cancer.

Authors:  James R Heath; Mark E Davis
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

Review 3.  Novel technologies for the discovery and quantitation of biomarkers of toxicity.

Authors:  Fitz B Collings; Vishal S Vaidya
Journal:  Toxicology       Date:  2007-12-05       Impact factor: 4.221

Review 4.  Non-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood.

Authors:  Jaclyn A Freudenberg; Kathryn Bembas; Mark I Greene; Hongtao Zhang
Journal:  Methods       Date:  2008-06-23       Impact factor: 3.608

5.  Is "liquid biopsy" useful for assessing HER2 status in gastric cancer?

Authors:  Hideaki Shimada
Journal:  J Gastroenterol       Date:  2014-05-14       Impact factor: 7.527

6.  Site-specific DNA-antibody conjugates for specific and sensitive immuno-PCR.

Authors:  Stephanie A Kazane; Devin Sok; Edward H Cho; Maria Loressa Uson; Peter Kuhn; Peter G Schultz; Vaughn V Smider
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-15       Impact factor: 11.205

Review 7.  Targeting erbB receptors.

Authors:  Zheng Cai; Hongtao Zhang; Jing Liu; Alan Berezov; Ramachandran Murali; Qiang Wang; Mark I Greene
Journal:  Semin Cell Dev Biol       Date:  2010-09-17       Impact factor: 7.727

Review 8.  Challenges in the clinical utility of the serum test for HER2 ECD.

Authors:  Lian Lam; Nicholas McAndrew; Marla Yee; Ting Fu; Julia C Tchou; Hongtao Zhang
Journal:  Biochim Biophys Acta       Date:  2012-04-03

9.  HIT: a versatile proteomics platform for multianalyte phenotyping of cytokines, intracellular proteins and surface molecules.

Authors:  Michael G Kattah; John Coller; Regina K Cheung; Neekaan Oshidary; Paul J Utz
Journal:  Nat Med       Date:  2008-10-12       Impact factor: 53.440

10.  Test for detection of disease-associated prion aggregate in the blood of infected but asymptomatic animals.

Authors:  Binggong Chang; Xin Cheng; Shaoman Yin; Tao Pan; Hongtao Zhang; Poki Wong; Shin-Chung Kang; Fan Xiao; Huimin Yan; Chaoyang Li; Lisa L Wolfe; Michael W Miller; Thomas Wisniewski; Mark I Greene; Man-Sun Sy
Journal:  Clin Vaccine Immunol       Date:  2006-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.